Actinobacillus pleuropneumoniae outer membrane lipoprotein A and uses thereof

US5891677A · kind A · utility

Assignee

• University of Saskatchewan · CA

Inventors

• Gerald F. Gerlach · Dresden, DE
• Philip Willson · Saskatoon, CA
• Amalia Rossi-Campos · Saskatoon, CA
• Andrew A. Potter · Saskatoon, CA

Key dates

• Filing date: Aug 15, 1995
• Grant date: Apr 6, 1999
• Expiry date: Aug 15, 2015

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y10S435/851
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Novel vaccines for use against Actinobacillus pleuropneumoniae are disclosed. The vaccines contain at least one Actinobacillus pleuropneumoniae outer membrane lipoprotein A, or an immunogenic fragment thereof. Also disclosed are DNA sequences encoding these proteins, vectors including these sequences and host cells transformed with these vectors. The vaccines can be used to treat or prevent porcine respiratory infections.